Trending Now
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Announces Q3 2020 Revenue Of $2.29 Boosted...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has announced its Q3 2020 financial results reporting 32% YoY increase in revenue to $2.29 billion and provided corporate updates.
Regeneron...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ambrx Biopharma Inc ($AMAM) rally could continue as biotech sector heats...
Ambrx Biopharma Inc (NYSE: AMAM) stock surged more than 1000% on Friday after the biotech company announced preliminary safety and efficacy data from...
MAKE IT MODERN
LATEST REVIEWS
Translate Bio Inc (NASDAQ:TBIO) To Present On Its mRNA Platform’s Potential...
Translate Bio Inc (NASDAQ:TBIO) has announced that it will be one of the companies presenting at the 34th Annual North American Cystic Fibrosis Conference...
MAKE IT MODERN
PERFORMANCE TRAINING
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) Finalizes Supplemental Biologics License Application Submission for Rylaze 
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) has announced that it has finalized the submission of a supplemental Biologics License Application to the US FDA for...
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Fiscal Q4 2020 Financials Highlight Failure To Turn A Profit
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) released its financials for its fiscal quarter ended June 30, 2020, revealing that the three months did not yield in...
TG Therapeutics Inc. (NASDAQ:TGTX) Reports Phase 3 GENUINE Study Results Evaluating Ublituximab and Ibrutinib...
TG Therapeutics Inc. (NASDAQ:TGTX) has announced final GENUINE third Phase study results for the evaluation of ublituximab’s combination and ibrutinb relative to using ibrutinib...
Dan Staner Of Moderna Inc (NASDAQ: MRNA) Says Covid Vaccine Will Be Delivered In...
Moderna Inc (NASDAQ: MRNA)’s European Head, Dan Staner, said the company would roll out covid vaccine in early Q3 2021 than previously planned.
Expects to...
The US FDA Accepts Zosano Pharma Corp (NASDAQ:ZSAN)’s NDA For Qtrypta To Treat Migraine
Zosano Pharma Corp (NASDAQ:ZSAN) received the US FDA's approval for NDA submission for its innovative drug – Qtrypta to cure migraine. If its Qtrypa...
MAKE IT MODERN
